Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET‐DD) study, a collaborative study carried out in 14 countries
Diabetic Medicine2018Vol. 35(6), pp. 760–769
Citations Over TimeTop 10% of 2018 papers
Cathy E. Lloyd, A. Nouwen, Norman Sartorius, Helal Uddin Ahmed, Adriana Álvarez, Silver Bahendeka, David Basangwa, А. Е. Бобров, Sylvia Boden, Viola Bulgari, Lorenzo Burti, Santosh K. Chaturvedi, Larry Cimino, Wolfgang Gäebel, Giovanni de Girolamo, Tomasz Gondek, M. Guinzbourg de Braude, Aravinda Meera Guntupalli, Martin Heinze, Linong Ji, Xin Hong, Ajmal Khan, Andrzej Kiejna, Andrzej Kokoszka, Thummala Kamala, Nebojša Lalić, Dušica Lečić Toševski, Boris Mankovsky, Mingwei Li, Abednego Musau, Karsten Müssig, David M. Ndetei, Golam Rabbani, S. Srikanta, Е. Г. Старостина, M. Shevchuk, Rizwan Taj, Olivera Vuković, Wolfgang Wölwer, Yaodong Xin
Abstract
Our international study, the largest of this type ever undertaken, shows that people with diabetes frequently have depressive disorders and also significant levels of depressive symptoms. Our findings indicate that the identification and appropriate care for psychological and psychiatric problems is not the norm and suggest a lack of the comprehensive approach to diabetes management that is needed to improve clinical outcomes.
Related Papers
- → Strong effects of environmental factors on prevalence and course of major depressive disorder are not moderated by 5-HTTLPR polymorphisms in a large Dutch sample(2012)31 cited
- → Comorbidity of ketamine dependence with major depressive disorder increases the vulnerability to neuroaxonal pathology(2023)19 cited
- A mega-analysis of genome-wide association studies for major depressive disorder(2013)
- → Machine Learning for Major Depressive Disorder: An Overview(2021)